WallStreetZenWallStreetZen

NASDAQ: NAUT
Nautilus Biotechnology Inc Stock Forecast, Predictions & Price Target

Open Broker Account
OverviewForecast
EarningsDividendOwnership

Analyst price target for NAUT

Based on 2 analysts offering 12 month price targets for Nautilus Biotechnology Inc.
Min Forecast
$2.00-5.66%
Avg Forecast
$4.00+88.68%
Max Forecast
$6.00+183.02%

Should I buy or sell NAUT stock?

Based on 3 analysts offering ratings for Nautilus Biotechnology Inc.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NAUT stock forecasts and price targets.

NAUT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Morgan Stanley
Bottom 7%
7
HoldMaintains$6.00+183.02%2022-08-03
Goldman Sachs
Bottom 6%
6
HoldMaintains$2.00-5.66%2022-08-03
Anonymous
Goldman Sachs
HoldMaintains$5.00+135.85%2022-04-13
Cowen & Co.
Bottom 9%
9
BuyInitiates Coverage OnN/AN/A2021-11-02

1 of 1

Forecast return on equity

Is NAUT forecast to generate an efficient return?
Company
-21.05%
Industry
18.02%
Market
121.74%
NAUT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NAUT forecast to generate an efficient return on assets?
Company
-19.12%
Industry
13.83%
NAUT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NAUT earnings per share forecast

What is NAUT's earnings per share in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
-$0.55
Avg 2 year Forecast
-$0.78
Avg 3 year Forecast
-$1.03

NAUT revenue forecast

What is NAUT's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$3.1M
Avg 2 year Forecast
$7.5M
Avg 3 year Forecast
$24.8M

NAUT vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NAUT$2.12$4.00+88.68%Hold
ACIU$3.16$10.00+216.46%Buy
FDMT$8.04$17.00+111.44%Buy
OMGA$5.42$9.50+75.28%Strong Buy
EYPT$7.91$23.00+190.77%Strong Buy
View Top Biotech Stocks

Nautilus Biotechnology Stock Forecast FAQ

Is Nautilus Biotechnology Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: NAUT) stock is to Hold NAUT stock.

Out of 3 analysts, 0 (0%) are recommending NAUT as a Strong Buy, 1 (33.33%) are recommending NAUT as a Buy, 2 (66.67%) are recommending NAUT as a Hold, 0 (0%) are recommending NAUT as a Sell, and 0 (0%) are recommending NAUT as a Strong Sell.

If you're new to stock investing, here's how to buy Nautilus Biotechnology stock.

What is NAUT's earnings growth forecast for 2022-2024?

(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 8.59%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.88%.

Nautilus Biotechnology's earnings in 2022 is -$61,645,000.On average, 2 Wall Street analysts forecast NAUT's earnings for 2022 to be -$68,564,752, with the lowest NAUT earnings forecast at -$69,811,384, and the highest NAUT earnings forecast at -$67,318,120. On average, 2 Wall Street analysts forecast NAUT's earnings for 2023 to be -$97,237,285, with the lowest NAUT earnings forecast at -$110,950,236, and the highest NAUT earnings forecast at -$83,524,335.

In 2024, NAUT is forecast to generate -$128,403,082 in earnings, with the lowest earnings forecast at -$128,403,082 and the highest earnings forecast at -$128,403,082.

What is NAUT's revenue growth forecast for 2022-2024?

(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.14%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.59%.

Nautilus Biotechnology's revenue in 2022 is $0.On average, 1 Wall Street analysts forecast NAUT's revenue for 2022 to be $386,455,877, with the lowest NAUT revenue forecast at $386,455,877, and the highest NAUT revenue forecast at $386,455,877. On average, 2 Wall Street analysts forecast NAUT's revenue for 2023 to be $938,713,791, with the lowest NAUT revenue forecast at $49,865,274, and the highest NAUT revenue forecast at $1,827,562,307.

In 2024, NAUT is forecast to generate $3,090,525,044 in revenue, with the lowest revenue forecast at $3,090,525,044 and the highest revenue forecast at $3,090,525,044.

What is NAUT's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: NAUT) forecast ROA is -19.12%, which is lower than the forecast US Biotechnology industry average of 13.83%.

What is NAUT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year NAUT price target, the average NAUT price target is $4.00, with the highest NAUT stock price forecast at $6.00 and the lowest NAUT stock price forecast at $2.00.

On average, Wall Street analysts predict that Nautilus Biotechnology's share price could reach $4.00 by Aug 3, 2023. The average Nautilus Biotechnology stock price prediction forecasts a potential upside of 88.68% from the current NAUT share price of $2.12.

What is NAUT's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: NAUT) Nautilus Biotechnology's current Earnings Per Share (EPS) is -$0.50. On average, analysts forecast that NAUT's EPS will be -$0.55 for 2022, with the lowest EPS forecast at -$0.56, and the highest EPS forecast at -$0.54. On average, analysts forecast that NAUT's EPS will be -$0.78 for 2023, with the lowest EPS forecast at -$0.89, and the highest EPS forecast at -$0.67. In 2024, NAUT's EPS is forecast to hit -$1.03 (min: -$1.03, max: -$1.03).

What is NAUT's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: NAUT) forecast ROE is -21.05%, which is considered weak.
©2022 WallStreetZen
Company
AboutBlogPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.